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Inflammation is a defensive mechanism stimulated when the body is attacked by 
pathogens or irritants, or when cells are damaged. Sometimes, these defensive 
mechanisms can go wrong, emerging to different inflammatory diseases, such as acute 
inflammation and chronic inflammation. Despite the existence of several anti-
inflammatory drugs on the market, new drugs with fewer side effects and higher efficacy 
are required for the treatment of inflammatory diseases. Attention has been given to 
natural bioactive compounds derived from marine organisms, since these are well known 
to be a source of potential bioactive compounds with different therapeutic applications in 
several diseases including inflammatory diseases. 
The aim of this research project was therefore to find compounds that can serve as new 
anti-inflammatory drugs or drug leads in microalgae. For that purpose, water, ethanol and 
ethyl acetate extracts of different microalgae species (Porphyridium sp., Nannochloropsis 
sp., Tetraselmis sp. CTP4, Isochrysis sp., Phaeodactylum tricornutum, Skeletonema 
costatum, Spirulina sp., Haematococcus pluvialis and Tetraselmis chuii) were 
characterized for its antioxidant activity as a pre-screening effort to select the most 
bioactive species/extracts. The most antioxidant extracts (ethanol extracts of 
Nannochloropsis sp., Tetraselmis sp. CTP4, and Tetraselmis chuii and water extracts of 
Nannochloropsis sp. and Porphyridium sp.) were afterwards screened for their anti-
inflammatory activity measuring the inhibition of TNF-α production by LPS-stimulated 
human macrophage-differentiated THP-1 cells (Mac-THP-1). The best results were 
obtained with the ethanol extract of Tetraselmis sp. CTP4 (87% inhibition of TNF-α at 
50 µg/mL in respect to the LPS control). This extract was therefore fractionated using 
liquid-liquid extraction (LLE), and the fractions were re-checked for their anti-
inflammatory activity, using the previous method in a bioassay-guided fractionation 
effort. The most active fraction (the hexane fraction) was later analyzed by GC-MS to 
tentatively identify some of the compounds present in the fraction that could be 
responsible for its anti-inflammatory properties. Most of the compounds identified were 
fatty acids, some of which had already been reported to have anti-inflammatory 
properties. Further studies are needed to identify the exact compound or compounds 
responsible for the anti-inflammatory effect in the active fraction. Nonetheless, these 
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results indicate that microalgae can be a source of compounds with the ability to minimize 
and reduce inflammation.  
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CHAPTER 1: INTRODUCTION 
 
1.1 Marine bioprospecting  
 
Since ancient times, natural compounds have been used in disease therapy and still play 
a major role in modern medication. About half of the drugs existing nowadays that have 
been approved since 1994 are based on natural products. It is recognized that plants, 
microorganisms, marine organisms, vertebrates, and invertebrates are essential sources 
for medicines1-2. In the past 30 years, the interest in marine bioprospecting has expanded 
among researchers in the globe. The marine environment is different from land-based 
ecosystems and offers great chemical diversity and high biochemical specificity. Very 
low octanol-water partition coefficient, more routable bonds and stereogenic centers are 
some of the chemical properties of small-molecule natural products that make them 
favorable as lead structures for drug discovery3-4. Marine organisms are therefore known 
to be as treasures that remain a relatively unexplored source for novel bioactive 
compounds that could eventually be transferred into therapeutics. 
However, as a consequence of the complex molecular structures of natural products, 
pharmaceutical companies have lately shifted to using synthetic chemical libraries. 
Hence, clinical trials for modern natural therapeutic products have decreased by 30% 
between 2001-20085. In addition to structural complexity, drug discovery from natural 
products faces many other challenges, such as the difficulty of organisms' collection, 
limited sample quantity, and problems associated with purification and identification of 
the active agents. When identified, the molecules are often complex which may be too 
difficult and expensive to produce synthetically. Besides, crude fractions of biological 
materials are not as amenable to high throughput screening as libraries of pure synthetic 
compounds3-6. Despite this decline, the utilization of natural products as a source of novel 
structures in drug discovery is still in progress. Since the 1980s, 174 new compounds 
were approved and commercialized, from which 93 (53%) are compounds from natural 
sources or isolated from them7. 
So far, the Food and Drug Administration (FDA) in the United States has approved three 
marine-derived drugs, namely Cytarabine 1 (Cytosar-U®, discovered in sea sponges), 
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Vidarabine 2 (Vira-A®, discovered in sponges), and Ziconotide 3 (Prialt®, discovered in 
cone snails). The applications for these drugs are cancer, viral infections and pain 
management, respectively8.  
 
Figure 1: Marine-derived drugs available in the marked8. 
 
In 2007, the European Union approved a marine-derived anticancer drug, Trabectedin 4 
(Yondelis®). In addition, 13 marine-derived compounds are either in phase I, phase II or 
phase III clinical trials, the pipeline of preclinical trials is giving a hundred novel marine 
compounds each year those compounds are potentially variable9. As mentioned, marine-
derived drugs have shown anticancer and antiviral activities. However, marine 
compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, 
antiprotozoal, and anti-tuberculosis effects, in addition to a number of other 
pharmacological activities are necessary for the treatment and prevention of diseases10. 
With several compounds approved as drugs, and a pipeline of agents in a clinical trial and 
preclinical evaluation, the marine environment has performed exceptionally well in 
yielding new drugs. This suggests that the value of marine natural products in new drug 
discovery will continue to be powerful in the years to come. There are two major methods 
in the research for the area of the natural products; old - and new methods11. The old 
method focuses on the chemistry of the compounds and the selection of natural sources 
going through ethnopharmacological information as well as traditional uses. However, 
the isolation and identification of compounds are being done before biological activity 
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testing (primarily in vivo). The new method, the so-called Bioactivity-guided isolation is, 
as the name says, highly focused on bioactivity. Biological assays (mainly in vitro) are 
being used to target the isolation and purification of the bioactive compounds. Organisms’ 
selection is going according to ethnopharmacological information and traditional use, but 
it can be chosen randomly as well. In the new method, natural marine sources are 
particularly used because marine natural products provide a great chance in the 
identification of newly bioactive compounds as drugs for different types of diseases 
treatment. 
The Marine Biodiscovery Process includes the biodiscovery pipeline for marine active 
bioactive compounds which is getting a biological material either via targeted sampling 
or through access to curated samples. This comprises analyses of the complete organism 
like sea squirts or sponges, or it could be sediments/cores of sediment from which 
microorganism can be isolated. In addition, microorganisms can be isolated from water 
samples to get sufficient biomass for active compound purification; the purified 
molecules and extracts can then be screened for the biological activity. The development 
process could be started if a promising result were obtained from the extracts and their 
purified molecules. However, that does not mean that always, results in a marketable 
product12. 
 
1.2 Inflammation  
 
Inflammation is a defensive mechanism stimulated when the body is attacked by for 
example pathogens, damaged cells or irritants. These responses are important for humans 
in fighting infections and for starting healing and recovering to normal function in the 
event of injury. Sadly, these defensive mechanisms sometimes can go wrong, and develop 
different inflammatory diseases. Inflammation is divided into acute inflammation, which 
is a short-term process taking place in response to tissue injury, or chronic inflammation, 
which refers to a slow, long-term inflammation lasting for prolonged periods of several 
months to years. Acute inflammation starts rapidly, becomes severe in a short time and 
symptoms may last for a few days, for example, acute pneumonia. It is marked by five 
cardinal signs: pain, redness, loss of function, swelling and heat. The extent and effects 
of chronic inflammation, however, may vary with the cause of the injury and the ability 
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of the body to repair and overcome the damage. Chronic and low-grade inflammatory 
diseases include rheumatoid arthritis, atherosclerosis, Alzheimer’s, asthma, psoriasis, 
multiple sclerosis, and inflammatory bowel diseases, and numerous of these 
inflammatory diseases are becoming universal13-14.  
As stated by the World Health Organization (WHO), about 235 million people suffer 
from asthma and it is a widely spread chronic disease among children. Approximately 
0.3–1.0% of the general population is suffering from rheumatoid arthritis15.The three 
fundamental groups of drugs used for the treatment of inflammatory diseases are 
corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs), and disease-modifying 
antirheumatic drugs (DMARDs). 
These drugs are commonly used and are effective in treating many inflammatory diseases. 
Corticosteroids show an important role in the therapy of organ transplantation due to their 
anti-inflammatory and immunosuppressive effects. However, they are related to some 
serious side effects. Corticosteroids are recognized to cause Cushing’s syndrome, in 
addition to other negative effects such as hyperglycemia, increased susceptibility to 
infection, psychiatric disturbances. On the other hand, NSAID, when used for the long 
term period, can lead to gastrointestinal ulceration and bleeding and platelet 
dysfunction14-16. 
 Inflammation is a complicated mechanism and it involves a multifactorial network of 
chemical signals to mediate the action. The first anti-inflammatory targets include cyclo-
oxygenase (COX)-1 and 2 enzymes, cytokines such as tumor necrosis factor (TNF)-α and 
interleukins (IL-1β, IL-6), and transcription factor as a nuclear factor (NF)-κB and several 
more. TNF-α and ILs have been recognized for their central role in the pathogenesis of 
numerous inflammation diseases, especially asthma and rheumatoid arthritis. TNF-α and 
ILs are intercellular signal proteins secreted by immune cells and have a lot of functions. 
The TNF-α function is responsible for a diverse range of signaling events within 
cells, leading to necrosis or apoptosis of the cells during acute inflammation in addition, 
the TNF-α protein is also important for resistance against infection and cancers. While 
the functions of ILs (Interleukins) is to regulate cell growth, differentiation, and motility, 
both are particularly important in stimulating immune responses, such as inflammation. 
The transcription factor NF-κB is the main regulator of the expression of several genes 
involved in the activation of inflammation. It is well established that the excessive 
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production of pro-inflammatory mediators is implicated in several inflammatory diseases. 
Therefore, inhibition of the overproduction of these mediators is a crucial, exciting target 
in the treatment of these conditions17-14-18. Herein, it is important to keep searching for 
new natural compounds possessing anti-inflammatory effects and reducing the side 
effects since the available drugs have a numerous side effect it’s important to keep 
searching for new drugs with anti-inflammatory properties and less side effects. The most 
common side effects produced by chemically synthesized drugs are gastrointestinal (GI) 
and renal effects associated with NSAIDs. However, sometimes the induced gastric or 
intestinal ulceration can be accompanied by anemia from the resultant blood loss19. 
 
1. 3 Natural sources of alternative anti-inflammatory agents 
 
It is worldwide recognized that natural products play a major role in the discovery 
pipeline for making and advancing of drugs for treating human diseases. Thus, natural 
products provide a great chance in the identification of bioactive compounds as drugs for 
the treatment of inflammatory diseases. Cyclosporine20 is a natural product that has been 
synthesized and developed as a first-line immunosuppressive medicine for the treatment 
of transplant rejection. The discovery of this compound in 1972 was accidental when it 
was isolated from the fungus Tolypocladium inflatum in Hardangervidda, Norway. 
Cyclosporine was approved for therapeutic use in 1983 and has since been an important 
medication, apart from transplants, in the treatment of inflammatory diseases like 
rheumatoid arthritis and psoriasis. The drug possesses many actions associated with the 
immunosuppressive activity, but the main action is the selective inhibitory effect on IL-2 
and IL-4 gene transcription. This example enlightens the powerful action of natural 
products as a source for drug discovery14-20. 
Lately, many anti-inflammatory pharmacologically active compounds from marine 
organisms have been identified. These compounds have been isolated and purified from 
numerous marine sources including sponges, mollusks, bryozoans, sea combs, algae, 
echinoderms, ascidians, and bacteria21-22-23-24. The Red alga Gracilaria verrucosa 
possessed anti-inflammatory activities by inhibiting lipopolysaccharide (LPS)-induced 
nitric oxide (NO) production, TNF-α, and IL625. Fatty acids can be pro-or anti-
inflammatory effects in macrophages by modulating the expression of the genes. 
6 | P a g e  
 
Specifically, n-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) have been reported 
to reduce the inflammatory gene expression via inhibition of nuclear factor κB 
signaling26. 
Astaxanthin, the major carotenoid pigment found in the marine world of algae and aquatic 
animals, have shown anti-inflammatory properties. Astaxanthin has exhibited anti-
inflammatory activities by suppressing the NF-κB activation. It inhibited the production 
of pro-inflammatory mediators such as TNF-α and IL-1β via doing in vivo studies27. 
Numerous of microalgae species were studied for the purpose of searching for anti-
inflammatory bioactive compounds. For instance, sulfolipids from Porphyridium 
cruentum have shown anti-inflammatory activity, the LCPUFAs existing in the crude 
sulfoquinovosyldiacylglycerols SQAG fraction.28 The LCPUFAs act as anti-
inflammatory compounds through the precursor compounds responsible for the 
amplification of the inflammation process and increasing the vascular permeability to 
allow self-propagating responses29. Porphyridium sp. polysaccharides derived from the 
red alga proved to have an anti-inflammatory effect, through interfering with the 
production of tumor necrosis TNF-α -induced inflammation, in human coronary artery 
endothelial cells30.The unrefined polysaccharides of Chlorella Stigmatophora and 
Phaeodactylum Tricornutum. extracts had anti-inflammatory activity in the carrageenan-
in Vivo studies in rats . Violaxanthin, isolated from Chlorella ellipsoidea showed an anti-
inflammatory effect when tested on lipopolysaccharide (LPS)-stimulated RAW 264.7 
mouse macrophage cells. Violaxanthin effectively inhibited LPS-mediated nuclear 
factor-κB (NF-κB) p65 subunit translocation into the nucleus, suggesting that the 
violaxanthin anti-inflammatory activity may be based on the inhibition of the NF-κB 
pathways31. The pigment-protein fraction (PPF) from Nannocloropsis oculate functioned 










 Microalgae are a very diverse assemblage of organisms and this diversity is reflected in 
the wide variety of chemical compounds of potential commercial interest that they 
produce. Microalgae are prokaryotic or eukaryotic photosynthetic microorganisms that 
can grow rapidly and live in harsh conditions due to their unicellular or simple 
multicellular structure. Prokaryotic microalgae include Cyanobacteria (Cyanophyceae), 
while green algae (Chlorophyta) and diatoms (Bacillariophyta) are examples of 
eukaryotic microalgae. Over the past few decades, microalgae have gained great interest 
due to their potential for many different production purposes. They are marine 
photosynthetic microorganisms capable to convert carbon dioxide into biochemicals that 
can be further processed into high-value bioactive compounds, biofuel and food 33. 
Microalgae can grow rapidly and occur in both aquatic and terrestrial environment, 
signifying a huge variety of species living in a wide range of condition and habitats. It is 
estimated that more than 50,000 species of microalgae exist, but only around 30,000, were 
studied and/or analyzed 34.  
The main obligation for the growth of algae is sunlight, water, and nutrients. Microalgae 
possess the capability to fix CO2 using solar energy with a performance 10 times better 
than that of terrestrial plants. The requirements of algae are very less than those of 
terrestrial plants for growing and they do not compete with agriculture or food for 
precious resources such as water, nutrient, and arable land35. The secondary metabolites 
produced by microalgae when exposed to severe conditions are being extracted from 
microalgae with the potential application in biomedicine and pharmacology in the modern 
field of microalgal biotechnology. The natural active compounds that occur in the 
microalgal biomass are accountable for distinct biological activities, such as cytotoxic, 
antibiotic, antioxidant, antifungal, anti-inflammatory and anthelminthic activity35-36. 
These days, there is different usage for microalgae, for example, microalgae can be 
utilized to improve the dietary benefit, they play a vital role in aquaculture and they can 
be used in cosmetic products36. The secondary metabolites delivered by microalgae are 
vitamins, proteins, lipids, pigments, and carbohydrates – for health, food, cosmetics and 
biofuel industries37. 
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1.5 Biomedical application of Microalgae 
 
1.5.1 Antioxidant activity 
 
Antioxidants are compounds that provide protection for living cells against free radicals. 
Free radicals are molecules produced when the body breaks down food or is exposed to 
tobacco smoke and radiation. The anti-oxidant gives electrons to the free radical and 
neutralize it. The natural secondary metabolites being produced by microalgae have been 
reported to possess antioxidant activity. As a result, microalgae have come to be a good 
source for the natural antioxidants, published by recent studies38.  
 
1.5.2 Anticancer activity 
 
Marine microalgae anti-cancer compounds were under investigation for a long time. The 
studies were done in the microalgal extracts or fractions obtained using the methods of 
extraction such as liquid-liquid partitioning or solid-phase extractions. It is uncommon to 
see dereplication methodologies, fractionations based on high throughput techniques 
(e.g., HPLC or gas chromatography) or a complete structural elucidation of the 
compounds that have been found. Despite the low data date available so far, the studies 
performed on Chlorella sorokiniana and Chaetoceros calcitrans show low activities 
compared to the commercially available marine anti-cancer drugs. Most of the 
pharmaceuticals on the market are active at the level of 0.6–7 ng/mL while the fractions 
from C. sorokiniana and C. calcitrans display significant activity at 1–3 µg/mL. Even if 
fractions and pure compounds cannot be directly compared in terms of activity, the anti-
cancer activities of C. sorokiniana and C. calcitrans extracts seem very promising and 
appear preferential for further investigation and purification of the active molecules. 
Despite the low yield (0.0001%) of the active compound in the crude aqueous ethanol 
extract of the ascidian Ecteinascidia turbinate39, this led to the isolation and development 
of the anti-cancer drug (trabectedin ET-743). 
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1.5.3 Antiviral activity  
 
Most of the compounds isolated form microalgae and used as antiviral are carotenoids 
from Haematococcus pluvialis and Dunaliella salina. Pressurized liquid extraction 
(PLE), an environmentally friendly technique, was used to obtain those compounds. The 
evaluation of the antiviral activity was done against herpes simplex virus type 1 (HSV-1) 
at different stages during viral infection. Results demonstrated that the use of PLE allows 
obtaining antiviral compounds from microalgae used as carotenoids sources, which gives 
both microalgae biomass an added40-41. 
 
1.5.4 Antibiotic activity  
 
Antimycobacterial activity was found in the hexane crude extracts of six microalgae: 
Chlamydomonas mexicana, Porphyridium cruentum, Isochrysis galbana, Rhodomonas 
sp., Aphanocapsa marina, and Nitzschia palea. All of the hexane extracts were able to 
inhibit 90% of the growth of Mycobacterium tuberculosis H37Rv at a concentration of 
100 µg/mL-1. The hexane crude extract of I. galbana possessed the highest 
antimycobacterial activity showing a percentage inhibition that was equal to that of the 
anti-tuberculosis drug isoniazid and having a minimum inhibitory concentration of 50 μg 
µg/mL-1. These findings demonstrate that microalgae are an excellent source for the 
search of novel antimycobacterial compounds42. 
 
1.6 Microalgae with cosmeceutical uses 
 
Numerous secondary metabolites isolated from algae are recognized for their skin 
benefits43. A worldwide tendency for products considered healthy, environmentally and 
ecologically sustainable, gained importance in cosmetics industries to fund the research 
and enhancement of new products with compounds or extracts of natural sources. Algae 
are natural sources of compounds against oxidative stress and have several efficient 
protection roles against reactive oxygen species and free radicals, producing compounds 
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that work in cosmetics towards the harmful effects of UV radiation, and similar acts of 
organic and inorganic filters that are nowadays being used in the market43. The production 
of both chlorophyll and carotenoids have been increased in C. vulgaris, Nostoc, and 
Spirulina platensis when cultivated in the presence of UV radiation43. Therefore, these 
compounds might assist in the protection against oil oxidation in formulations, largely in 
emulsions with a huge quantity of oily phase, since they possess antioxidant properties. 
Fucus vesiculosus extract is used to decrease the dark circles appear on the skin zone 
under the eye via stimulating the expression of heme oxygenase-l, a molecule that 
terminates the heme construction on the skin by removing heme catabolites. The extract 
with anti-inflammatory activity and antioxidant properties can make a better appearance 
of eye bags, and collagen production is stimulated which can assist to reduce fine lines 
and wrinkles. Besides, it can diminish or prevent skin aging by using make-up and 
sunscreens44. Several secondary metabolites of specific microalgae can avoid blemishes, 
repair damaged skin, treat seborrhea, inhibit several inflammation processes and speed 
up the healing process, and maintain skin moisture45.  
Furthermore, red algae extracts are being used in hair care, emollient, sun protection, 
skincare, refreshing or regenerate care products, anti-aging creams, and anti-irritant in 
peelers45-46. Algae are mainly incorporated in cosmetic formulations as thickening, water-
binding and antioxidants agents. However, more than a single contribution could be 
attributed to each species, as reported in.47.  
 
1.7 Natural products drug discovery from microalgae 
 
In this study, a bioassay-guided isolation strategy was applied to obtain molecules 
possessing anti-inflammatory effects isolated from marine microalgae, which could 
provide the market with a new natural compound to be used as an anti-inflammatory drug 
in the future. 
The steps needed for the preparation of the material before extraction includes the 
collection of the microalgal biomass, species identification, and storage of the samples. 
There are different extraction methods available, however, the selection of the extraction 
method is based on the nature of the source material and the purpose of the isolation. 
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Extraction is a process of getting one or more compounds from a solid matrix or pull out 
of a solute from a liquid to another liquid (liquid-liquid extraction). Solid samples are 
most of the time being cut into small fragments or ground into fine particles in order to 
accelerate solvents penetration. Stirring or shaking can be used to advance the diffusion 
rate. The solvents that were used int this project for the preparation of the extracts were 
water, ethanol and ethyl acetate the reason behind selecting different solvents is to obtain 
different compounds presents in the microalgae since the extraction depends on the 
polarity index of solvents and compounds. The produced extracts can then be tested in 
the different bioassays depending on the objective. Often, a simple antioxidant test 
activity is done before testing with other more complex and expensive, such as the anti-
inflammatory assays. Afterwards, based on the antioxidant results, the most promising 
extracts can be selected for further bioactivity (anti-inflammatory) assays. Anti-
inflammatory assays can be performed with macrophages stimulated with a pro-
inflammatory drug (i.e. LPS). A pre-incubation with the extracts is used to test for anti-
inflammatory action through monitoring the inhibition of TNF-α production. Often, 
human THP-1 cells are used and differentiated into macrophage THP-1 cells (Mac-THP-
1). The production of TNF-α is afterward measured using sandwich enzyme-linked 
immunosorbent assay (ELISA) which is an analytical biochemistry assay, first described 
by Engvall and Perlmann in 1972. The assay uses a solid-phase enzyme immunoassay to 
detect the presence of a ligand in a liquid sample using antibodies directed against the 
protein to be measured. Active extracts can undergo bioassay-guided fractionation until 
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1.8 THP-1 cells  
 
The THP-1 cell line (Figure 2: A) is a human monocytic leukemia cell line settled by 
Tsuchiya et al., in 1980. It was isolated from the blood of a patient suffering from acute 
monocytic leukemia. THP-1 cells are similar to primary monocytes and macrophages in 
morphology and differentiation characteristics. THP-1 cells have a large, round single-
cell morphology and show distinct monocytic markers. Mostly all THP-1 cells start to 
adhere to culture plates and differentiate into macrophages (Figure 2: B) after being 
exposed to phorbol-12-myristate-13-acetate (PMA, also known as TPA,12-O-
tetradecanoyl phorbol-13-acetate) 
THP-1 cells have some technical advantages over human primary monocytes or 
macrophages. For instance, their genetic background is homogeneous which minimizes 
the degree of variability in the cell phenotype. Another technical advantage is that genetic 
modification of THP-1 cells by small interfering RNAs (siRNAs), in order to down-
regulate the expression of specific proteins, is relatively simple48. THP-1 differentiated to 
macrophages have been used as a model in vitro at this research for the anti-inflammatory 
investigation. 
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1.9. OBJECTIVE  
 
 The main objective of this master thesis is to search for a new drug lead for anti-
inflammatory treatment in extracts of commercialized microalgal biomass (Porphyridium 
sp., Nannochloropsis sp., Tetraselmis sp. CTP4, Isochrysis sp., Phaeodactylum 
tricornutum, Skeletonema costatum, Spirulina sp., Haematococcus pluvialis, and 
Tetraselmis chuii). To fulfill the main objective, several specific sub-objectives were 
underlined: 
1. To prepare ethanol, water and ethyl acetate extracts of the above-mentioned 
species. 
2. To test the prepared extracts for antioxidant activity. A pre-screening for the 
antioxidant activity will help to identify and select the most promising extracts for 
the more expensive anti-inflammatory assays; 
3. To test the most antioxidant extracts for anti-inflammatory activity, namely by 
measuring the production of TNF- by LPS-stimulated THP-1 macrophages; 
4. To fractionate the most active extract and produce a fraction with higher activity 
and less complexity than the initial extract; 
5. To perform a chemical characterization of the most active fraction to identify 
known bioactive compounds (e.g., phenolics, vitamins, and polyunsaturated fatty 
acids); 
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CHAPTER  2: MATERIAL AND METHOD   
 
2.1 Chemicals  
 
Solvents used for extraction and fractionation: dimethyl sulfoxide (DMSO), methanol, 
dichloromethane (DCM), ethanol (EtOH), ethyl acetate (EA), hexane, were commercial 
grade with 96% purity (VWR International, Leuven, Belgium). For the GC derivatization, 
analytical grade solvents were purchased from the same source. Ultrapure, Type 1 water 
was obtained using a MilliQ® Water Purification System (Darmstadt, Germany). Roswell 
Park Memorial Institute medium (RPMI-1640) and fetal bovine serum (FBS), L-
glutamine (200 mM), penicillin/streptomycin mixture, Phorbol 12-myristate 13-acetate 
(PMA), were all from Sigma-Aldrich, St. Louis, MO, USA. MTS 3-(4,5-dimethylthiazol-
2-yr)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium was from the Cell 
Titer 96® Aqueous Non-Radioactive Cell Proliferation Assay (Promega Corporation, 
Madison USA). Butylated hydroxytoluene (BHT), phenazine methosulfate (PMS) and 
2,2-diphenyl-1-picrylhydrazyl (DPPH) powder were from Aldrich, Sigma (USA), and the 
TNF- Elisa kit from PeproTech. 
 
2.2 Algal biomass   
 
Algal biomass of the following species: Porphyridium sp., Nannochloropsis sp., 
Tetraselmis sp. CTP4, Isochrysis sp., Phaeodactylum tricornutum, Skeletonema 
costatum, Spirulina sp., Haematococcus pluvialis, and Tetraselmis chuii, were kindly 
provided by NECTON S.A. (Portugal). This is a company specialized in the cultivation 
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2.3 Preparation of extracts  
 
The biomass of each microalga was extracted with ethyl acetate, ethanol, and water. The 
ratio was 1g of biomass from each algal species to 40mL of the three different solvents 
prepared in separated flasks. Five grams of dried biomass was mixed with 200 mL of 
ethanol, ethyl acetate, or distilled water. The extractions were performed overnight (16 
h), at room temperature (RT) with agitation using magnetic stirring. (Figure 3: A). After 
extraction, the mixture was transferred to 50 mL Falcon tubes (Figure 3: B) and 
centrifuged (Thermo Scientific, USA) at 726.1g for 5min in order to separate the extracts 
from the remaining biomass. The extracts were filtered through a filter of 10-12 µm pore 
size (Prat Dumas, France). This process was repeated three times. Finally, the 
supernatants were combined and vacuum-filtered, using 0.45 µm and 0.2 µm filters 
sequentially (Figure 3:C). The solvents were evaporated in a rotary evaporator (IKA, 
RV10, IKA, Germany) to reduce the volume of the extract (Figure 3:D). The concentrated 
extract was transferred to a smaller pre-weighed vial and completely dried under a gentle 
nitrogen flow. The yield was determined, and the extracts resuspended in dimethyl 




Figure 3:A: Extraction of the biomass using different solvents through stirring at room temperature. B: 
filtration of the extract. C: the vacuum filtration system consisting of a funnel coupled with a kitasato flask 
connected to water flow hose. D: evaporating the extract in a Rotary Evaporator. 
 
 
A B C D 
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2.4 Extract fractionation  
 
The most active extract, Tetraselmis sp. CTP4 ethanol was selected for fractionation. The 
fractionation was done by liquid-liquid extraction (LLE), which is a purification 
technique that is used to separate compounds based on their relative solubilities in two 
immiscible solvents. Immiscible liquids do not dissolve in each other; they form layers 
when placed in the same glassware. Immiscibility is a result of two liquids having 
different polarity. LLE started by mixing the ethanol extract with water (20:80) and 
extracting sequentially with hexane (H), dichloromethane (DCM), and ethyl acetate (EA) 
in a separating funnel. The procedure yielded 4 fractions: H, DCM, EA and the remaining 
ethanol/water (E/W) fraction. For this fractionation, 3 g of the Tetraselmis sp. CTP4 -
ethanol extract, already prepared, was mixed with 20 mL EtOH and 80 mL of Milli-Q 
water and placed in a separation funnel. 50 mL of hexane was added to the mixture and 
shook gently. After phase separation, the hexane (top) layer was collected in a glass round 
bottom flask (Figure 4: A). The water layer was re-extracted with another 50 mL of 
hexane and the process repeated until 150 mL of hexane fraction was collected (three 
extractions in total). After the extraction with hexane, the ethanol/water fraction was 
sequentially extracted with 3 x 50 mL of DCM and 3 x 50 mL of EA. The remaining 
fraction (a mixture of ethanol and Milli-Q water) was collected as well. All the fractions 
were concentrated in a rotary evaporator, transferred to a 45 mL vial size and dried under 
gentle nitrogen flow (organic fractions) or freeze-dried (E/W fraction). Part of each 
fraction was re-dissolved in DMSO at 20 mg/ mL for further anti-inflammatory analysis. 
However, the rest of the fractions were stored dried at – 20°C. All the fractions (hexane, 
dichloromethane, ethyl acetate, and water-ethanol) (Figure 4: B) were analysed for anti-
inflammatory activity on macrophage differentiated THP-1 cells, as described above. The 
fraction with the highest activity was chemically characterized by gas chromatography-
mass spectrometry (GC-MS) to tentatively identify the major compounds present, and 
possibly responsible for the observed anti-inflammatory and antioxidant activity 
visualized at the start point of the assay processing. 
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The fractions yield displayed as a percentage (%) in relative to the starting mass of the 
extract led for fractionation (3 g) and the calculations were done according to the 
following equation:  
(𝑚1 − 𝑚2 )𝑥100  where m1 (g) corresponds to the weight of the extract residue after 
solvent removal; m2 (g) is the weight of the dry biomass. 
 
 
Figure 4-A: The process of collecting the fractions. B: Fractions obtained. 
 
2.5 Free Radical Scavenging Activity  
 
 The 2,2-Diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging activity is 
considered a basic common test for antioxidant activity assessment. DPPH is a stable free 
radical which has a purple color in solution (Figure 5). When scavenged by antioxidant 
molecules it is reduced to diphenyl picryl hydrazine, which has a yellow color in solution. 
This property allows the visual monitoring of the reaction, and free radical scavenging 
activity can be calculated by measuring the absorption changes at 517nm.  
18 | P a g e  
 
 
Figure 5: DPPH radical capturing a hydrogen atom from an antioxidant molecule. 
 
The DPPH assay was determined using the method described by Moreno et al. (2006) 49. 
A solution of 120 µM DPPH in methanol was prepared daily. The experiment was done 
on a 96 well plate (WVR, USA) (Figure 6). The extracts were tested at 1, 5 and 10 mg/mL 
and butylated hydroxytoluene (BHT) was used as a positive control . DMSO was used as 
a negative control. Extracts (22 μL) were mixed with 200 μL of DPPH solution (120 μM 
in methanol) in 96-well microplates. After a 30-min incubation period in the dark, the 
absorbance was measured at 515 nm using a microplate reader spectrophotometer 
(Biotech 4 Multi-Detection, USA). The antioxidant activity was calculated as the 
percentage inhibition relative to a blank containing DMSO in place of the samples, using 
the following equation:  
 % 𝑖𝑛h𝑖𝑏𝑖𝑡𝑖𝑜𝑛 = 
𝐴𝑏𝑠𝑛𝑒𝑔 𝑐𝑜𝑛𝑡𝑟𝑜𝑙− 𝐴𝑏𝑠𝑡𝑒𝑠𝑡 𝑠𝑎𝑚𝑝𝑙𝑒
𝐴𝑏𝑠𝑛𝑒𝑔 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 ×100 
Where   Abstest sample  =  Abs test solution – Abs  color control. 
 
IC50, which is the biochemical half maximal inhibitory concentration, was determined for 
the extracts with radical scavenging activity (RSA)( antioxidant activity) higher than 50% 
when tested at 10 mg/mL. 
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Figure 6: Antioxidant assay performed for ethyl acetate extracts at 10,5 and 1 mg/mL on the same plate. 
A: Tetraselmis sp.CTP4; B:  Skeletonema costatum; C Nannochloropsis sp oculate; D: BHT and DMSO as 
positive and negative controls, respectively. 
 
2.6 Anti-inflammatory assay  
 
2.6.1 Cell cultivation and differentiation 
 
THP-1 cells were kindly provided by Dr. Nuno Santos (CBME, University of Algarve, 
Faro, Portugal) and were cultivated in RPMI 1640 media containing 1% L-glutamine, 
10% heat-inactivated FBS, 1% penicillin-streptomycin (PS), and 1% non-essential amino 
acids. THP-1 cells were routinely maintained in RPMI 1640 medium at 37 ̊C in a 5% CO2 
humidified atmosphere. To differentiate the THP-1 monocytes into macrophages (Mac 
THP-1), cells were plated in 96 wells plates (2.5×105 per well) in 200 µl/well of RPMI 
1640 medium, supplemented with 25 ng/mL of phorbol 12-myristate 13-acetate (PMA), 
for 48h.  
2.6.1.1 Cell counting  
 
To calculate the volume of cell suspension required to plate 2.5𝑥105cells/well, cells 
counting was made using a Neubauer chamber (VWR International, Leuven, Belgium) 
(Figure 7) following the equation: 
 
 
A B C D 
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𝑁 =
A + B + C + D
4
 x  𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 𝑥 104  
where N represents a number of cells/mL; A, B, C, D correspond to the number of cells 
in each quadrant of the counting chamber and 104 is a conversion factor.  
 
Figure 7:  Neubauer counting chamber. The average count of the cells in squares multiplied by 10000 
gives a number of cells per mL (A) (source: www.trade21.com; www.fishersci.co.uk) 
 
2.6.2 Cell viability assessment (MTS assay) 
 
Extracts were tested for cytotoxicity on Mac THP-1 cells before the anti-inflammatory 
assays. Cell viability was assessed using the MTS method (Cell Titer 96® Aqueous Non-
Radioactive Cell Proliferation Assay, USA). Mac THP-1 cells were differentiated as 
described above for 48h. T After this period, the cells were inspected under a microscope 
to confirm that the monocytes had differentiated to macrophages by adhering to cell 
culture plate, and that cells were evenly distributed in every well. Then the old media was 
removed, and new media, containing the five extracts: water extract of Porphyridium sp., 
and Nannochloropsis sp. and ethanol extract of Nannochloropsis sp., Tetraselmis sp. 
CTP4, and Tetraselmis chuii was added. The same process was done to assess the 
fractions (hexane, dichloromethane, ethyl acetate, and water/ethanol) resulting from the 
fractionation of the active extract. All were tested at a concentration of 10, 20 and 50 
µg/mL. Also, DMSO vehicle at the highest concentration of 0.25% (v/v) was tested to 
make sure that the vehicle is not toxic. Testing conditions were added to the pre-
differentiated cells, and further incubated for 48 hours. Afterwards, 11.9 μL of MTS (3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
21 | P a g e  
 
tetrazolium) plus 0.6 μL of phenazine methosulfate (PMS) to a final volume of 120 μL 
RPMI media were added. The plate was incubated at 37°C, with 5 % CO2 for 1h and the 
absorbance measured at 490 nm using a spectrophotometer (Biotech 4 Multi-Detection, 
USA). All the values were compared to the control untreated cells, considered to have 
100% of cells viability. The cells viability (%) was calculated after the treatments. The 
average of the blank absorbance was taken first and subtracted from all the measurements 
on the 96-well plate, to determine the background noise. The average of the control wells 
(cells without treatment) was calculated representing 100% cells viability. The cell 
viability of the DMSO control, positive control, and cells treated with the extracts and the 
fractions were then calculated by the following formula:  
% cell viability = 
𝐴𝑏𝑠𝑠𝑎𝑚𝑝𝑙𝑒  − 𝐴𝑏𝑠𝑐𝑜𝑛𝑡𝑟𝑜𝑙 
𝐴𝑏𝑠𝑐𝑜𝑛𝑡𝑟𝑜𝑙 
× 100 
Where 𝐴𝑏𝑠𝑠𝑎𝑚𝑝𝑙𝑒= absorbance of the extracts/fractions treated with the cells  
𝐴𝑏𝑠𝑐𝑜𝑛𝑡𝑟𝑜𝑙 = absorbance of untreated cells with the extracts/fractions 
 
2.6.3 Inflammatory assay in Mac THP-1 cells 
 
THP-1 cells were plated and differentiated to macrophages (Mac THP-1) as described in 
the previous section. After differentiation, cells were treated with extracts/fractions at 
concentrations of 10, 20 and 50 µg/mL, or not treated corresponding to the basal 
conditions of Mac THP-1 cells. Also, a positive control to the anti-inflammatory response 
was performed, by treating the cells with dexamethasone at 2 μM. This pre-treatment was 
performed for 24 hours. Inflammation was induced by adding 100 ng/mL of LPS to all 
wells, except for the negative control condition corresponding to cells without treatment, 
for additional 24 hours. All the extracts were tested in triplicates for each concentration. 
The conditioned media was collected and centrifuged for 15 minutes at 13.000 rpm and 
4ºC to remove the cell debris and kept at -20°C until ELISA.  
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2.6.4 Evaluation of the anti-inflammatory activity through quantification of TNF- 
by sandwich ELISA 
 
The enzyme-linked immunosorbent assay (ELISA) is a commonly used 
analytical biochemistry assay, first described by Engvall and Perlmann in 1972. The 
assay uses a solid-phase enzyme immunoassay (EIA) to detect the presence of 
a ligand (commonly a protein) in a liquid sample using antibodies directed against the 
protein to be measured. ELISA has been used as a diagnostic tool in medicine, plant 
pathology, and biotechnology, as well as a quality control check in various industries50. 
The types of common ELISA assays include direct, indirect and sandwich ELISA.  A 
sandwich ELISA assay (Pepro tech, USA) was used in this study. A sandwich ELISA 
quantify antigens detected by two antibodies (i.e. capture and detection antibody), 
directed against two epitopes on the target molecule. Either monoclonal or polyclonal 
antibodies can be used as the capture and detection antibodies in a sandwich ELISA 
system. Monoclonal antibodies recognize a single epitope that allows fine detection and 
quantification of small differences in antigen. A polyclonal is often used as the capture 
antibody to pull down as much of the antigen as possible. The advantage of sandwich 
ELISA is that the sample does not have to be purified before analysis, and the assay can 
be very sensitive. 
 
2.6.4.1 Sandwich ELISA assay for the determination of TNF-α production by Mac 
THP-1 induced by LPS. 
 
Sandwich ELISA was used for the determination of TNF-α production by Mac THP-1 
induced by LPS. Capture antibodies Rabbit Anti-Human TNF-α (PeproTech, USA) were 
plated after been prepared in Phosphate-buffered saline (PBS) to a concentration of 1.0 
μg/mL. 100 μL of the solution was added to each well and the plate kept at room 
temperature overnight. Then, aspiration of the liquid took place and the plate was washed 
4 times with 300 μL wash buffer/well (wash buffer: 1xPBS with 0.05 % of Tween-20). 
Followed by the addition of 300 µl/well of blocking buffer (1 % of  BSA diluted in 1x 
PBS and incubated for 1 hour at room temperature. The PBS concentrated 10x was 
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prepared from these compounds (15mMof  𝑁𝑎2𝑃𝑂4, 𝑁𝑎𝐻2𝑃𝑂4,8.1mM 
𝑁𝑎𝐻2𝑃𝑂4. 2𝐻2𝑂, and 1.45M NaCl) in Milli-Q water with 7.3-7.4 of pH.  
Briefly, the conditioned media from the samples such as negative control (cells without 
treatment) were diluted 1:20 while the rest of the samples, including the inflammatory 
positive control (Mac THP-1 cells treated only with LPS), the anti-inflammatory positive 
control dexamethasone and the conditions with the tested extracts/fractions, were diluted 
1:75. A serial dilution from 2000 pg/mL to zero human TNF-α standard was performed. 
Thus, the human TNF-α standard concentrations were 2, 1, 0.5, 0.25, 0.125, 0.0625, 
0.03125, 0.0156 pg/mL in Assay diluent ( 0.1% of BSA in 1xPBS containing 
0.05%Tween-20). The plate was incubated at room temperature for 2 hours. The plates 
were washed with 300ul of wash buffer per well 4 times.  
The detection antibodies, Biotinylated Rabbit Anti-Human TNF-α solution was prepared 
to a concentration 50μg/mL in a diluent, and 100 μL was added to all wells. The plates 
were kept at room temperature for 1 hour followed by washing and addition of 100 μL of 
avidin-HRP conjugate solution diluted (1:2000) to all wells. The plates were incubated at 
room temperature for 30 minutes before they were washed with wash buffer 300 μL wash 
buffer/well, 4 times. Next, 100 μL ABTS (2.2-Azino-bis (3-ethylbenzo-thiazoline-6-
sulfonic acid) liquid substrate solution was added to all wells, and the plate was taken to 
the Microplate Reader spectrophotometer. Kinetic reading of the absorbance at 405 and 
650nm was determined for each well at 5 minutes interval. The concentration of TNF- α 
in the samples was determined using the calibration curve obtained from the Human TNF-
α standard. Also, the percentage of  TNF-α inhibition by the extracts and fractions was 
calculated in respect to the LPS -proinflammatory control, according to the following 
equation: 
% of TNF- α 𝑖𝑛h𝑖𝑏𝑖𝑡𝑖𝑜𝑛 = 
LPSproinflammatory control − Sample 
LPSproinflammatory control 
 ×100 
Where LPSproinflammatory control = Quantity of the TNF- α production in  Mac THP-1 
cells treated only with the pro-inflammatory LPS 
Sample=Quantity of the TNF- α production in the cells treated pre-treated with 
extracts/fractions and proinflammatory LPS. 
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2.7 Chemical characterization by GC-MS 
 
2.7.1 Chemical derivatization 
 
 Based on the anti-inflammatory results of the fractions, the H fractions were selected for 
chemical characterization by GC-MS. For this purpose, the fractions were derivatized in 
order to make it more volatile since GC measures the volatile compounds. The 
derivatization was done according to a modified protocol of Lepage and Roy51. This 
method is based on the direct transesterification with acetyl chloride/methanol, followed 
by direct extraction of the derivatized compounds into hexane. Briefly, 10mg of each 
fraction was weighed and treated with 1.5 mL of derivatization solution (methanol/acetyl 
chloride, 20:1, v/v), in reaction vessels. Afterward, 1 mL of hexane was added, and the 
mixture heated for 1 hour at 100°C. After cooling in ice baths, 1 mL of distilled water 
was added, and the organic phase removed and dried with anhydrous sodium sulfate. The 
extract was then filtered and stored at −20 °C until further analysis.  
 
2.7.2 GC-MS analysis 
 
Fractions were analyzed on an Agilent GC-MS (Agilent Technologies 6890 Network GC 
System, 5973 Inert Mass Selective Detector) equipped with a DB5-MS capillary column 
(25 m × 0.25 mm internal diameter, 0.25 μm film thickness, Agilent Tech) using helium 
as the carrier gas. Samples were injected at 300°C and the temperature profile of the GC 
oven was 60°C (1 min), 30°C min−1 to 120°C, 5°C min−1 to 250°C, and 20°C min−1 to 
300°C (2 min). For the identification of the compounds present in the fractions, the total 
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2.8 Statistical analysis and data interpretation  
 
2.8.1 Statistical analysis for radical scavenging activity  
 
The Abs color control is the Abs recorded for the (DMSO) negative blank control. The 
IC50  values were calculated for those species in which antioxidant inhibition was more 
than 50%. IC50. The half-maximal inhibitory concentration is a measure of the potency 
of a substance in inhibiting a specific biological or biochemical function. IC50 values were 
estimated with GraphPad Prism v.7.0, by the sigmoidal fitting of the data.  
 
2.8.2 Statistical analysis of sandwich ELISA assay  
 
The results are presented as a mean ± standard deviation; all analyses were performed in 
triplicate in three independent experiments. Differences between species and the LPS 
control were assessed using analysis of variance (one-way ANOVA by Dunnett’s 
multiple compressions tests). Significant differences were considered when p < 0.05 by 
means of the statistical program Graph Pad Prism (release 7.0). 
 
2.8.3 Statistical analysis for the GC-MS 
 
Bruker MSWS Software was used with integrated National Institute Standard and 
Technology (NIST) library to identify the compounds present in the active fraction 
Components’ relative percentages were calculated based on GC peak areas in respect to 
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CHAPTER 3:  RESULTS AND DISCUSSION   
 
3.1 Screening for antioxidant activity    
 
The screening for the antioxidant activity was performed with the ethanol (EtOH), ethyl 
acetate (EA) and water (W) extracts obtained from Porphyridium sp. (POC), 
Phaeodacytlum tricornutum (PHA), Nannochloropsis sp. (NANNO), Tetraselmis sp. 
CTP4 (T.CTP4), Isochrysis sp. (ISOG), Skeletonema costatum (SKLT), Spirulina sp. 
(SPR), Tetraselmis chuii (T.Chuii), Haematococcus pluvialis (H Pluvialis).  
Thus, extracts were tested for antioxidant activity with the DPPH assay. where the 
presence of compounds that are able to neutralize the free radical DPPH is determined. 
All the values obtained were presented as a percentage, compared to the positive control 
butylated hydroxytoluene (BHT)52. All the samples were analyzed at concentrations of 1, 
5 and 10 mg/mL. The response of all the extracts was dose-dependent (Table 1), that is, 
DPPH scavenging activity was increased by the increasing concentration of the 
antioxidant compounds present in the samples53.Since all the extracts were dissolved in 
DMSO prior to the experiment, DMSO was used as a negative control as well, tested at 
the same concentration as in the extracts. Due to its medium polarity, DMSO is a preferred 
solvent in extract testing assays for a wide range of compounds, as it can dissolve both 
polar and nonpolar compounds; in addition, it is miscible with water54. The results for the 
average antioxidant activity  are summarized in Table 1. The best results were 
accomplished was with the EA extracts, showing the highest antioxidant activity when 
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3.1.1 Screening of ethyl acetate extracts for their antioxidant activity 
 
The POC EA extract results reached to 21.4%, 89.6% and 104% for the 1,5 and 10 mg/mL 
respectively. These values indicate that the best results were achieved with POC EA with 
considerably higher antioxidant activity when compared to other extracts (Table 1). The 
antioxidant activity for POC EA reached 104 % and 86.6% at 10 and 5 mg/mL 
respectively, showed higher activity when compared to NANO EA 81%, Tetraselmis sp. 
CTP4 EA  37%, and SKLT EA with 72.3% at 10 and 5 mg/mL concentrations. However, 
in the case of PHA EA and ISOG EA, good results were obtained with 10 mg/mL, 
reaching the antioxidant activity of 94% and 97%, respectively. These values were 
significantly higher when compared to POC EA (89%) at 5mg/mL. 
Some previous studies showed the apparent antioxidant activities of polysaccharides 
isolated from other Porphyridium species (P.cruentum), however, they also revealed that 
the molecular weight (MW) of the polysaccharides was related to their biological 
activities55.  Phaeodactylum tricornutum..was also reported possessing an antioxidant 
activity by measuring the phenolic content and carotenoid content 56. Also, Isochrysis 
galbana methanol extract displayed antioxidant activity. It was indicated that the total 
phenolic and carotenoid content play a vital role in the antioxidant activity57.  
Skeletonema costatum was reported to have a moderate antioxidant activity influenced by 
their carotenoid and phenolic continent58. However, Nannochloropsis oculata, 
Tetraselmis sp. CTP4 and Tetraselmis chuii were not previously assessed for antioxidant 
activity. 
 
3.1.2 Screening of water extracts for their antioxidant activity 
 
Water extract of Porphyridium sp. (POC W) also showed good results in terms of 
scavenging activity with 87.5% at 10 mg/mL.  
And the results obtained at 5 mg/mL showed 32.1% of antioxidant activity was higher 
when compared to Tetraselmis sp. CTP4 W (23.24%) and PHA W (24.17%), both at 10 
mg/mL concentration. On the other hand, ISOG W and NANNO W antioxidant activity 
results were 42% and 51.9% respectively at 10 mg/mL concentration. This value showed 
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significantly higher antioxidant activity when compared to the other water extracts at 10 
mg/mL (Table 1). 
 
3.1.3 Screening of ethanol extracts for their antioxidant activity 
 
The best antioxidant activity for the ethanol extracts tested was for Haematoccoccus 
pluvialis with antioxidant activity of 103% and 77% at 10 and 5 mg/mL, respectively. 
These values with antioxidant activity at 5 mg/mL were higher compared to POC 
antioxidant activity T. CTP4. ISOG. PHA, SKILT, SPR. sp. and T. Chuii. All at 10 
mg/mL as shown in Table 1. Despite of having a high antioxidant activity 
Haematoccoccus pluvialis was not selected since it was reported that astaxanthin 
produced by this species possess both antioxidant and anti-inflammatory 59. 
On the other hand, NANNO was an exception, presenting significantly lower antioxidant 
activity with 80.37%, when compared to H. Pluvialis at 10 mg/mL for both of them (Table 
1). High antioxidant activity of Haematoccoccus pluvialis ethanol extract might be due 
to the carotenoid astaxanthin, as reported previously, and it could be a promising source 
to be used as a natural alternative antioxidant agents59. Also, Spirulina platensis is 
reported to be considered as a potential antioxidant agent60.These results go in the same 
line in term of antioxidant activity possessed by most of the species screened here. 
However, Tetraselmis sp. CTP and Tetraselmis chuii both ethanol extracts were not 
reported before for antioxidant activity. Nonetheless, Nannochloropsis sp. was reported 
to be a potential source for antioxidants compounds due to the presence of a substantial 
amount of polyunsaturated fatty acids and carotenoids61. 








Table 1: Radical Scavenging Activity (RSA) (antioxidant activity ) of DPPH free radicals of water (W), ethanol 
(EtOH) and ethyl acetate (EA) extracts of the different microalgal species, applied at three concentrations (1, 5 and 10 
mg/mL). nd – no activity detected. Values are presented as mean ± standard deviation. 
Extract  Solvent used DPPH        
  
1 mg/mL 5 mg/mL 10 mg/mL 
Porphyridium sp. Water 5.02 ± 1.75 32.1 ± 5.6 87.5 ±10.0 
Porphyridium sp. EtOH 0.49 ± 1.17 30.36 ± 1.33 59.1± 1.0 
Porphyridium sp. EA 21.4±1.9 89.6±0.8 104.5±2.6 
Nannochloropsis sp. Water nd 46.8 ± 9.4 51.0 ± 5.2 
Nannochloropsis sp. EtOH 3.95 ± 2.97 53.7 ± 2.6 80.3±2.3 
Nannochloropsis sp. EA 4.72±0.91 36.8±1.5 81.7±2.2 
Tetraselmis sp. CTP4 Water 00.2 ± 5.0 12.0±2.3 23.2 ± 3.7 
Tetraselmis sp. CTP4 EtOH 8.72 ± 0.70 36.0± 1.4 58.1 ±1.5 
Tetraselmis sp. CTP4 EA 0.14±2.35 17.12±1.70 37.8±3.2 
 Isochrysis galbana   Water nd 21.3 ± 3.5 42.2± 3.3 
 Isochrysis galbana  EtOH 1.69 ± 1.31 21.8± 1.2 41.6 ± 0.2 
 Isochrysis galbana   EA 17.2± 2.6 51.9±2.0 97.8±2.1 
Phaeodactylum  tricornutum. Water 0.50 ± 0.57 12.3± 1.2 26.8 ± 2.2 
Phaeodactylum  tricornutum.. EtOH 0.05 ± 1.67 32.4 ± 1.4 61.8 ±1.3 
Phaeodactylum  tricornutum.. EA 13.2±1.4 61.7± 2.1 94.9±3.3 
Skeletonema sp. Water nd 16.5 ± 2.9 24.1 ± 3.1 
Skeletonema sp. EtOH 4.9 ± 0.8 36.0 ± 2.0 71.1 ± 1.2 
Skeletonema sp. EA 23.9± 1.7 60.0± 2.3 73.3± 7.25 
 Spirulina sp.  EtOH 15.6 ± 3.5 49.4 ± 2.8 71.5 ± 0.3 
Tetraselmis chuii   EtOH 22.2± 5.1 45.3 ± 0.4 66.8 ± 1.0 
Haematococcus pluvialis EtOH 4.94 ± 7.63 77.2 ± 54.1 103.6± 58.2 
BHT  94.1±2.8   
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3.1.4 Determination of  𝐈𝐂𝟓𝟎 for the extracts with antioxidant activity above 50% 
 
The IC50 was determined for the extract exerted antioxidant activity higher than 50%. As 
shown in Figure 9. The best IC50 achieved was with Porphyridium sp.(POC).ethanol 
extract, Porphyridium sp.(POC)water extract,  Nannochloropsis sp.(NANNO) ethanol 
extract, Skeletonema sp.(SKILT) ethanol extract, Skeletonema sp. (SKILT)  ethyl acetate 
extrct, Phaeodactylum sp.(PHA)ethanol, Phaeodactylum sp.(PHA) ethyl acetate,, and 














































































































































































Figure 8:Radical scavenging activity (𝐈𝐂𝟓𝟎: mg/mL) of ethyl acetate, ethanol, and water extracts of the 
different microalgae screened values are mean with standard deviation values not sharing the same letter  
are significantly different from one another (P＜0.05). 
 
 Most of the extracts contain a lot of compounds such as phenolic, polysaccharides, 
carotenoids, polyunsaturated fatty acid, and vitamins, and all of these compounds were 
reported to be responsible for providing antioxidant activity partially or completely62-55-
63. However, other studies showed that carotenoids are a major contributor to the 
antioxidant activity in some species64. 
31 | P a g e  
 
The interest in compounds possessing high antioxidant activity from natural sources is 
constantly growing. The reason behind this is the role they play in the protection against 
oxidative stress, which has been associated with several chronic disorders with a special 
focus on neurodegenerative diseases65. Porphyridium sp, Isochrysis galbana and  
Phaeodactylum sp  EA extracts and Haematococcus pluvialis ethanol extract showed 
similar or even higher activity to that of synthetic antioxidant BHT (showed in Table 2), 
used here as a positive control. BHT is a lipophilic organic compound derived from 
phenol, active for antioxidant activities66. 
The high antioxidant activity for the ethyl acetate extract could be due to the high 
efficiency of the solvent in solubilizing flavonoids, which are polyphenolic compounds 
present in the extract prepared67. However, H. pluvialis ethanol extract showed the highest 
activity compared to BHT and all extracts. This could be due to the fact that ethanol is 
considered a good solvent for extracting polyphenols present in the microalgae species, 
which might be responsible for the antioxidant property68. 
Despite the high antioxidant activity for the ethyl acetate extracts, these were excluded 
from further analysis of anti-inflammatory screening activities, due to the evidence that 
non-polar extracts are often more toxic to cells  lines69. Therefore, the ethanol extracts of 
Tetraselmis sp. CTP4, Tetraselmis chuii, and Nannochloropsis sp., and the water extracts 
of Porphyridium sp., and Nannochloropsis sp. were chosen to be screened for the anti-
inflammatory activity in the next step of this study. The microalgae extracts exerting the 
high antioxidant activity are a potential new source of natural antioxidants and other 
bioactive compounds. However, apart from ethyl acetate extracts, some other ethanol 
extracts were not selected. This was due to that they or their compounds were already 
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3.2 Anti-inflammatory assays 
 
 3.2.1 Cell viability assessment for the extracts 
 
For the MTS assay, Mac THP-1 cells were used to assess potential cytotoxic effect of the 
microalgae extracts. In the anti-inflammatory assays, compounds tested should not 
exhibit any observable toxic effect on the Mac cells, as cells can release the inflammatory 
marker TNF-α, which is then quantified using ELISA sandwich method. Extracts and 
were applied for 48h in different concentrations (10, 50 and 100µg/mL).and DMSO was 
also applied separately at 0.25% (v/v) concentration. Then cytotoxicity was assessed 
using the MTS assay. The cell viability results as showed in Figure 10 indicate that most 
of the extracts screened for the cytotoxicity were non-toxic, as the reduction of the cell 
viability did not go below 80%, except for the water extracts for both Porphyridium sp. 
And Nannochloropsiss sp. 
 
Figure 9: MTS cytotoxicity assay screened at 100, 50 and 10 μg/mL for Porphyridium sp. Water 
(POC (Water)), Nannochloropsis oculate ethanol (NANNO ethanol) Nannochloropsis oculate water 
NANNO water ), Tetraselmis sp. CTP4 ethanol (T. CTP4 ethanol) and Tetraselmis Chuiie ethanol (T. 
chuii ethanol). C: negative control (cells without treatment. D: DMSO (DMSO treated with the cells 
only). 
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Applying MTS reagent on Mac THP-1 cells, large amounts of a brown formazan were 
produced upon incubation with above-mentioned extracts at different concentrations. 
This indicates normal cell metabolism and normal mitochondrial integrity. Ethanol 
extracts of all species tested at the tested concentrations of 10, 50 and 100 µg/mL, did not 
show any toxic effect to Mac THP-1 cells, with cell viability above 80%. However, water 
extracts of both of Porphyridium sp. and Nannochloropsis sp. were slightly toxic at 100 
µg/mL reducing cell viability of Mac THP-1 to approx. 60%. Due to this, the 
concentrations used for further anti-inflammatory screening were 50, 20 and 10 µg/mL 
for all extracts (Figure 9). 
 
3.2.2 Cytokines targeted by anti-inflammatory drugs    
 
Macrophages have an important role in the starting, maintaining and resolution of the 
inflammation caused by the stimulation with the lipopolysaccharide (LPS), which is a 
bacterial endotoxin. Macrophages respond to the LPS stimulation by secreting large 
amounts of pro-inflammatory cytokines such as TNF-α, IL-1 which in turn further 
increase the inflammatory response via further activation of macrophages. This is the 
reason behind targeting cytokines released by macrophages in therapeutic interventions, 
for the purpose of controlling the inflammatory response74. Most of the anti-inflammatory 
drugs used are antagonists of the inflammatory cytokines, such as IL-1-receptor 
antagonist (anakinra) and TNF-α antagonists (infliximab, etanercept, and adalimumab)75. 
Despite the fact that anti-inflammatory drugs from natural compounds showed 
remarkable success, the cost and numerous adverse effects they cause still limit their 
application74. In this study, one of our objectives was to suppress the TNF-α cytokine 
production by the THP-1 differentiated macrophages (Mac THP-1), for the application of 
extracts obtained from different microalgae species as an anti-inflammatory. ELISA 
assay was used to detect and quantify the production of TNF-α cytokine. In addition, 
dexamethasone (DXM), which is a well-known anti-inflammatory drug, was used as a 
positive control in the study. 
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3.2.3 The screening of ethanol extracts for anti-inflammatory activity against THP-
1 macrophage cells (Mac THP-1)  
 
Anti-inflammatory activity screening of ethanol extracts, previously shown to be non-
toxic to Mac THP-1 cells, Tetraselmis sp. CTP4 (T.CTP4), Tetraselmis chuii (T.chuii), 
and Nannochloropsis sp. (NANO), were assessed against human THP-1 cells 
differentiated to macrophages (Mac THP-1) . Mac THP1- cells were pre-treated with the 
extracts and dexamethasone (DXM), which is being used as an anti-inflammatory 76 drug. 
In addition, cells treated with LPS only, without any pre-treatment was used as a positive 
control to the inflammatory reaction.  
Three experiments were performed in triplicates for each concentration tested and the 
results are expressed as the concentration of TNF- per experimental condition (Figure 
11), and as the average inhibition of TNF-α (%) in respect to the LPS-induced 
proinflammatory control (Table 2) (Figure 10). 
Both Tetraselmis sp. CTP4 and T. chuii ethanol extracts showed an interesting TNF-α 
downregulation in respect to the LPS control at 50 µg/mL, reaching 82% and 47% 
respectively. Tetraselmis sp. CTP4 showed a dose-dependent response with a TNF- 
inhibition of 55% and 46% at 20 and 10 µg/mL, respectively. The T. chuii showed similar 
anti-inflammatory activities at 20 and 10 µg/mL, with reduction of TNF- α from 49% to 
53% respectively. The reduction of the positive control (DMX) at 2µM reached 57% in 
respect to the LPS control. These values suggest that Tetraselmis sp. CTP4 at the highest 
concentration tested of 50 µg/mL, had the best TNFα inhibition activity, even when 
compared to the positive DXM control. T.chuii ethanol extract showed the highest 
inhibition of TNF-α at the lowest concentration (10 µg/mL), compared to the other two 
concentrations used, with suppression reaching 54% (Table 2).  This might be due to 
several reasons since we are dealing with a complex natural extract. One of the reason, 
which might cause this higher inhibition at the lower concentration, is due to some 
compounds being present in the extract, that has the ability to mask the agents which are 
responsible for the anti-inflammatory effect. However, at the lowest concentration, the 
effect of the inhibition is similar to the positive control, which exhibited 53% of TNF- α 
inhibition. TNF- α inhibition might be increased by fractionation of this extract. To our 
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knowledge, this is the first time that Tetraselmis sp. CTP4 and was screened for the anti-
inflammatory activity. One reason for this is the fact that Tetraselmis sp. CTP4 was 
recently isolated and identified1. However, both Tetraselmis sp. CTP4 and T.Chuii 
presented statistical significance with respect to the LPS control group. 
 Regarding the Nannochloropsis sp. (NANO) ethanol extract, the results of TNF-α 
suppression reached 31%, 26 and 40% (Table 2) (Figure 10) at the 50, 20 and 10 µg /mL, 
respectively. These results were not as promising as the previous two extracts, but it is 
noteworthy to mention that the highest suppression rate of TNF-α occurred at the lowest 
concentration. Both the highest and the lowest concentrations tested were statistically 
different when compared to the LPS control (Figure 10). However, no statistical 
difference between control and NANNO ethanol extract was observed at 20 µg/mL, with 
26% of TNF-α inhibition. As mentioned previously, there are many different compounds 
present in natural complex extracts, and sometimes, the presence of antagonistic receptor 
ligand, blocking or dampening a biological response could be responsible for the 
observed effect.  
For further investigation of this issue, fractionation needs to be performed in order to 
reduce the number of compounds with potential anti-inflammatory activity in each 
fraction, so that the identification of responsible compound for the observed effect could 
be facilitated.  
Much of the current literature on extracts suppressing TNF- produced by Mac THP-1 
induced inflammation pays particular attention to bioactive compounds responsible for 
this activity. Methanol extract of C. vulgaris was reported to be significant different TNF-
α inhibitor when compared to LPS control at concentration 125 µg/mL tested. This 
suggests that C. vulgaris  has anti-inflammatory activity and could be a potential source 
of anti-inflammatory agents of natural origin77. Moreover, other species that were 
reported to have TNF-α inhibition were Cylindrotheca closterium , Odontella 
mobiliensis, Pseudonitzschia pseudodelicatissima, C. actinocyclus, and A. minutum.  All 
these species showed a significant decrease of TNF- when compared to the LPS control 
at 10, 25, 50 and 100 µg/mL78. However two tested concentrations for that studies are 
similar to the concetraions that we used( 10 and 50 µg/mL) and they showed significance 
compared to the LPS control. This is a reason to believe that our results with Tetraselmis 
sp. CTP4 are very promising with possible use as an anti-inflammatory agent. Since the 
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most promising result was obtained from Tetraselmis sp. CTP4 ethanol extract, and the 




Table 2:  % of  TNF-α inhibition caused by ethanol extracts at 50, 20 and 10 
μg/mL in Mac THP-1 cells, relative to the LPS control, data are presented in 
percentage and standard deviation. 
Extract  Concentration % 
Dexamethasone  2µM 
                     
57.0±8.6  
Tetraselmis sp. CTP4 ethanol 50μg/mL  83.0±9.4 
Tetraselmis sp. CTP4 ethanol 20μg/mL 56.0±5.1 
Tetraselmis sp. CTP4 ethanol 10μg/mL  46.0±6.7 
Tetraselmis chuii ethanol 50μg/mL  47.0±12.4 
Tetraselmis chuii ethanol 20μg/mL 49.0±9.6 
Tetraselmis chuii ethanol 10μg/mL  54.0±5.0 
Nannochloropsis oculate ethanol 50μg/mL  31.0±16.1 
Nannochloropsis oculate ethanol 20μg/mL 26.0±17.8 
Nannochloropsis oculate ethanol 10μg/mL  40.0±2.6 



















Figure 10:Anti-inflammatory activity of extract, Nannochloropsis oculate , Tetraselmis sp. CTP4  and Tetraselmis chui  sp. all are ethanol 
extracts, in Mac THP-1 cells stimulated with LPS, as determined by levels of TNF-α in the cell culture media. Data are the means ± S.D. of 
three independent experiments. * p < 0.05, ** p < 0.005, ***p < 0.0005, ****p < 0.0001 vs LPS control. CTR, negative control (cells without 
treatment); LPS, LPS pro-inflammatory control; DXM, Dexamethasone positive anti-inflammatory controls: ns, no significance, (50, 20 and 
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3.2.4 The screening of water extracts for anti-inflammatory activity against THP-1 
macrophage cells (Mac THP-1)  
 
 During the next step of this study, water extracts obtained from Porphyridium sp. (POC) 
and Nannochloropsis sp. (NANNO) were screened for anti-inflammatory activity in Mac 
THP-1 cells.  However, obtained results were not as promising as the ethanol extracts 
described in the previous section. The results achieved for the TNFα inhibition by POC 
were 32%, 4% and 20 % of inhibition for the 50, 20 and 10 µg /mL, respectively (Table 
2). Yet, these results were not significantly different in comparison to the LPS control 
except for the highest concentration (50 µg /mL) (Table 3)(Figure 11).   A previous study 
has described a potent anti-inflammatory activity of isolated polysaccharides from this 
microalga on Angiotensin II-stimulated human coronary artery endothelial cells79. 
However, the water extract used in this study is not expected to contain a high amount of 
polysaccharides, since their solubility in the water is low due to the long chains. 
For the Nannochloropsis sp. (NANO), the results for all the concentrations tested were 
below 25% of TNFα inhibition (Table 3), and they were not significantly different from 
the LPS control group (Figure 11).  
Our results suggest that ethanol extracts might display higher anti-inflammatory activity 
than water extract. This might be due to ionic and polar substances present in water, that 
is not cell membrane permeable, and therefore unable to reach a potential cellular target. 
At this step, both water extracts were excluded from further studies, and ethanol extract 








   
Table 3:  % of TNF-α inhibition  caused by  water extracts  at 50, 20 and 10 
μg/mL in Mac THP-1 cells, relative to the LPS control, data are presented in 
percentage and standard deviation. 
Dexamethasone  2µM 57.0±8.6 
Porphyridium sp.water 50μg/mL  33.0±2.4 
Porphyridium sp.water 20μg/mL 05.0±17.9 
Porphyridium sp.water 10μg/mL  21.0±3.6 
Nannochloropsis oculate water 50μg/mL  0 
Nannochloropsis oculate water 20μg/mL 26.0±11.6 
Nannochloropsis oculate water 10μg/mL  18.0±17.6 























Figure 11: Anti-inflammatory activity of , Nannochloropsis oculate , Porphyridium cruentum  both are water extracts in Mac THP-1 
cells stimulated with LPS, as determined by levels of TNFα in the cell culture media. Data are the means ± S.D. of three independent 
experiments. * p < 0.05, ** p < 0.005, ***p < 0.0005, ****p < 0.0001 vs LPS control. CTR, negative control (cells without treatment); 
LPS, LPS pro-inflammatory control; DXM, Dexamethasone positive anti-inflammatory control,   ns, no significance , (50, 20 and 
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During the last few years, a remarkable proportion of compounds with an anti-
inflammatory effect were discovered in the marine environments. Due to the issues 
regarding the serious side effects of the traditional anti-inflammatory drugs, the need for 
novel anti-inflammatory drugs is increasing. The aim of this research was to find and 
investigate the anti-inflammatory activities of extracts from microalgae. Thus, all foreign 
substances present in the extracts that are not being recognized by the cells might trigger 
the inflammatory response. These non-specific interactions may also occur between 
extracts and Mac THP-1 cells and trigger the production of IL-1β and TNF-α, or maybe 
the concentrations of the substances present in the extract are too high so that they interact 
non-specifically with a receptor in the cells. Since the screening for compounds exerting 
anti-inflammatory activities was not always easy owing to the complexity of cellular 
interactions involved during an inflammatory response, the same extracts were tested in 
3 experiments in triplicates for each one. The data generated from 3 experiments made it 
possible to compare whether the results were consistent with each other. This concluded 
that the most promising result obtained was with Tetraselmis sp. CTP4 ethanol extract. 
           
3.3 Fractionation of Tetraselmis sp.CTP4 ethanol extract 
 
Our previous results showed that Tetraselmis sp. CTP4  (T.CTP4)ethanol extract was the 
most promising species in regard to the anti-inflammatory activity in Mac THP-1 cells. 
Therefore, it was subjected to a four-step fractionation process using solvents of different 
polarity indexes. The polarity and the chemical nature of the solvent used in the extraction 
method are responsible for the extraction yield, the composition, and thus biological 
activity of a given extract since they will have different compounds both qualitatively and 
quantitively 80. In this way, in order to obtain the knowledge on the phytochemical 
composition and bioactivity profile of the microalgal species selected for fractionation, a 
sequential extraction process using funnel separation with extremely non-polar 
hexane(H), medium polar dichloromethane (DCM) and ethyl acetate (EA), and polar 
water was performed. Water was added to ethanol to increase the polarity of the ethanol 
extract and favour the extraction of the non-polar and intermediate polarity compounds 
to the other solvents. With this method, more diverse fractions are obtained, and the 
bioactive compounds might be more concentrated in some of the fractions. This way, 
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false-negative results are minimized as well. The algal neutral/nonpolar lipids such as the 
mono-, di- and tri-acyl glycerides and carotenoids are hydrophobic81-82. Thus, these non-
polar compounds are extractable by the hexane solvent since it is non-polar with a polarity 
index of 0.1. 
The DCM solvent is a moderately polar solvent with a polarity index of (3.1). This solvent 
will probably extract both polar and non-polar compounds such as pigments and the 
hydrophilic polar lipids (phospholipids and glycolipids) present in the microalgal 
extract82. Thus, polar compounds could also be extractable by the ethyl acetate solvent 
since its more polar with a polarity index of 4.4. In addition, most intermediate polarity 
compounds would be extracted with the DCM since its polarity is much closer to the 
polarity of the ethyl acetate, hence the lowest yield was obtained for the EA fraction.  
However, the solvent with the highest polarity used here was water with a polarity index 
of 10.2 and ethanol with a polarity index of 4.8, was added in the begging of the 
fractionation. This combined fraction W/EtOH was the last fraction to be collected and 
was expected that all the polar compounds would remain in this fraction.  The yield of 
this fraction was the largest (Table 4) comparing the other fractions yield obtained. This 
is due to the high polarity of both combined solvents (water and ethanol). It was assumed 
that this fraction would contain most of the polar compounds in the extract. The yield of 
the hexane fraction was the second largest (Table 4) after the combined ethanol-water 
fraction, and this is due to the previous explanation that all non-polar compounds present 
in the extract would be extracted by hexane.  
 
Table 4: The yield quantity for both extract and fractions obtained.  
 
 
Species Solvent  Yield (g) Fraction Yield (g) 
Tetraselmis sp. CTP4 Ethanol 3g Hexane 0.599 
   Dichloromethane 0.0475 
   EA 0.0105 
   Water/ EtHO 1.6532 
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3.3.1 Cell viability of the fractions of Tetraselmis sp. CTP4 extract  
 
MTS assay was performed to test potential cytotoxicity of fractions prior to the anti-
inflammatory assay. Mac THP-1 cells were treated with different doses (10, 20 and 50 
g/mL) of hexane (H), dichloromethane (DCM), ethyl acetate (EA), and ethanol-water 
(E-W) fractions and DMSO was added as well separately at 0.25% (v/v) concentration 
all of them for 48 h. The results showed almost no cell toxicity in all the fractions tested 
since none of them decreased the cell viability below 90% (Figure 12). Instead, cell 
proliferation was observed at the highest concentrations for H and EA fractions. In this 
regard, observed increased metabolic activity induced by high concentrations of the 
different fractions can only mean cell proliferation. This means that cells were 
metabolically active, viable and were also able to grow in the presence of the fractions at 
all concentrations (10, 20 and 50 g /mL). 
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Figure 12: MTS cytotoxicity assay screened at 50, 20 and 10 μg/mL for hexane, dichloromethane (DCM), 
ethyl acetate (EA) and ethanol/water (EtOH/water) fractions. C: negative control cells without treatment. 
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3.3.2 Anti-inflammatory activity of fractions obtained from Tetraselmis sp. CTP4 
ethanol extract against THP-1 macrophage cells (Mac THP-1)  
 
The same assay used to check the anti-inflammatory effect of the extracts explained above 
was applied for the fractions as well. 
In the secondary screening for the anti-inflammatory activity, the best results were 
obtained with hexane (H) and dichloromethane (DCM) fractions. Both H and DCM 
fractions showed very promising TNFα inhibition in Mac THP-1 cells, with respect to the 
LPS control (Figure 13). At 50 µg/mL they hit 99% and 100% of TNF- α inhibition, 
respectively (Table 5). The hexane fraction induced inhibition of 98% and 97%, at 20 and 
10 µg/mL, respectively. 
Nonetheless, the DCM showed a slight decrease in the TNF-α inhibition with 89% and 
87% at concentrations of 20 and 10 µg/mL, respectively. Both fractions showed higher 
activity at all concentrations when compared to the positive control DXM that reached 
70%.  
In addition, both of the fractions presented levels of TNF-α similar to the non-stimulated 
control cells, at the highest concentration tested (Figure 13). This indicates that those 
fractions display strong anti-inflammatory activity, even at the lower concentration tested, 
with a higher effect than DXM. This might suggest that a complex mixture with a lot of 
compounds can have a higher anti-inflammatory effect that a purified compound used as 
an anti-inflammatory drug, which in our case is DXM. If the compound responsible for 
this anti-inflammatory effect was isolated and purified, it may have the same effect as the 
DXM, but with considerably lower concentration administered. Since the drug potency is 
a measure of the drug activity, expressed in terms of the amount required to produce an 
effect of given intensity, highly potent drugs (e.g., fentanyl, alprazolam, risperidone) 
evoke a given response at low concentrations, while a drug of lower potency 
(meperidine, diazepam, ziprasidone) evokes the same response only at higher 
concentrations83. And that means that our fraction contains a compound or compounds 
with high potency, could be used as a potential anti-inflammatory drug. In fact, both H 
and DCM showed significantly highest downregulation of the TNF-α in respect to the 
LPS control at all concentrations (Figure 13). 
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 Ethyl acetate (EA) and Water/ethanol (W/E) fractions at 50 µg/mL inhibited TNF-α 
production by 90% and 5 %, respectively (Table 5). Ethyl acetate fraction showed a really 
interesting result at the highest concentration, in which the suppression of TNF-α in Mac 
THP-1 cells, reached 90%. This result at this concentration was close to the exhibited 
activity of DCM at 20 µg/mL, that reached 89% (Table 5). Yet, the result of EA at 20 and 
10 µg/was not that interesting, with no effect of inhibition at 20 µg/mL, and 35% of TNF-
α inhibition at 10 µg/mL (Table 5). However, this might be due to several impacts like 
freezing and defrosting the extract each time prior use may cause some degradation and 
the extract may lose the activity. This part might need to be repeated for better 
confirmation of the observed effect. Yet, this EA fraction showed that it might contain a 
compound which would have an interesting anti-inflammatory effect if purified. Hence 
the effect showed at 50 µg/mL was really interesting compared to DXM positive control. 
Ethanol/water (W/E) fraction TNF-α downregulation results at 20 and 10 µg/mL were 
32% and 1% respectively (Table 5). However, W/E was not significantly different 
compared to LPS pro-inflammatory control (Figure 13). These results could be due to that 
most of the bioactive compounds were extracted by H, DC, and EA fractions. W/E 
fraction was the last fraction to be collected during the fractionation for the the 
Tetraselmis sp. CTP4 ethanol extract. Based on these results, the hexane fraction was the 
most promising and interesting fraction among all the others, which was the reason behind 






Table 5: % of TNF-α inhibition caused by different fractions   
at 50, 20 and 10 μg/mL in Mac THP-1 cells, relative to the LPS 
control, data are presented in percentage and standard deviation 
Fractions  Concentrations % 
Dexamethasone  2µM 70.0±5.6 
Hexane fraction   50μg/mL  99.0±0.8 
Hexane fraction   20μg/mL 98.0±2.0 
Hexane fraction   10μg/mL  97.0±1.7 
Dichloromethane fraction  50μg/mL  100±1 
Dichloromethane fraction 20μg/mL 89.0±3.4 
Dichloromethane fraction 10μg/mL  87.0±11.4 
Ethyl acetate fraction 50μg/mL  90.0±9.1 
Ethyl acetate fraction 20μg/mL  0 
Ethyl acetate fraction 10μg/mL 35.0±32.0 
Water/Ethanol fraction  50μg/mL  05.0±46.1 
Water/Ethanol fraction  20μg/mL 32.0±38.0 
Water/Ethanol fraction  10μg/mL  1.0±55.4 














Figure 13:Anti-inflammatory activity for (hexane, dichloromethane, ethyl acetate and ethanol/water) fractions of Tetraselims sp CTP4 
extracts  in Mac THP-1 cells stimulated with LPS, as determined by levels of TNF-α in the cell culture media. Data are the means ± S.D. of 
three independent experiments. * p < 0.05, ** p < 0.005, ***p < 0.0005, ****p < 0.0001 vs LPS control. CTR, negative control (cells without 
treatment); LPS, LPS pro-inflammatory control; DXM, Dexamethasone positive anti-inflammatory control, ns, no significance , (50, 20 and 
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3.4 Chemical composition of the hexane fraction obtained from Tetraselmis 
sp. CTP4 by GC–MS  
 
In the above sub-chapter, our results demonstrated that the hexane fraction was the most 
active fraction with promising anti-inflammatory activity in terms of TNF- suppression  
by 98%, 97% and 96% at concentrations of 50, 20 and 10 g/mL, respectively. In order 
to identify the compound possibly responsible for the anti-inflammatory effect, this 
fraction was analysed by GC/MS. 
In the GC-MS analysis, 42 compounds were successfully identified (Table 6). The 
compounds were identified by comparing the mass spectra of each peak with the spectral 
data of different compounds obtained from the NIST library. Twelve of the identified 
compounds were already reported by other authors, to possess anti-inflammatory activity. 
These 12 compounds could be responsible for the observed effect of our extract. 
These 12 compounds were: octadecenoic acid, hexadecatrienoic acid, octadecadienoic 
acid stearidonic acid, heptadecanoic acid, hexadecenoic acid, hexadecene-1-ol, valeric 
acid 1, docosahexaenoic acid, linolenic acid, eicosapentaenoic acid, and vitamin E. 
Furthermore, from these 12 compounds, only 8 were reported to act as an antioxidant. 
 Fatty acids derived from marine organisms have varies chemical structures which serve 
as a biological marker. They possess biological activity due to the characteristic of the 
living environment. Numeral studies have reported the activity of essential fatty acids 
from seaweed. For example,  ω-3 and ω-6 obtained from Undaria pinnatifida could act 
as anti-inflammatory84 agents. Most of the compounds identified in our sample were fatty 
acids which have been reported in different studies to possess anti-inflammatory effect85. 
Most of the microalgae produce fatty acids in high quantities and Tetraselmis sp. CTP4 
is one of them1. In addition, the dietary intake of fatty acids is important to the human 
body. In particular, eicosapentaenoic (EPA) and docosahexaenoic acids (DHA), were 
reported to lower the incidence of cardiovascular diseases86. 
 From the table 4 below, it can be seen that the most abundant compounds detected by 
GC-MS corresponded to Octadecenoic acid, hexadecatrienoic acid, and Octadecadienoic 
acid with 28.71%, 12.63%, and 6.12% for the total peak area, respectively. 
47 | P a g e  
 
In published literature octadecenoic acid, from the macroalga Sargassum wightii was 
shown to possess anti-inflammatory activity against the inflammatory marker 
Cycloxigenase-2 87. Furthermore, this compound is reported to improve the anti-oxidant 
activity associated with decreased expression of maturation markers in LPS-matured DCs 
,and in murine enterocyte cells (MODE-K)88. In the line of previous studies, 
hexadecatetraenoic acid isolated from the algae U. pinnatifida and Ulva pertusa was 
reported to have an anti-inflammatory effect using MC/9 Mouse Mast Cell model89. 
In addition, other published study reported that octadecadienoic acid from the marine red 
alga Gracilaria verrucosa acted as an anti-inflammatory agent against nitric oxide (NO), 
IL-6, and TNF- production, in LPS stimulated RAW 264.7 cells90. The same compound 
derived from Peperomia pellucida leaf extract was reported to possess antioxidant 
activity as well as 91. Sardonic acid was relatively abundant in our fraction, with 4.49% 
of the peak area. It was shown by other researchers that this compound extracted from 
microalgae present in the marine environment, exhibits an anti-inflammatory effect by 
inhibition of mouse ear inflammation induced by phorbol myristate acetate90.  
The results of heptadecanoic acid with of 2.79% of total peak area ties well with a 
previous study in which this compound isolated from Ziziphus jujube Mill, a Chinese date 
acted as an anti-inflammatory agent against the irritant action of Euphorbiaplants92. This 
compound was not reported to act as an antioxidant in other studies. Overall the finding 
of hexadecanoic acid with an abundance of 1.61% are in accordance with previous 
findings reported to have an anti-inflammatory effect93. in addition, this compound is used 
in cosmetics, in make-up products,  to hide blemishes94. A similar effect was achieved by 
another study in which 9-Hexadecen-1-ol isolated from the chlorophyll showed an anti-
inflammatory effect95. Both valeric acid and docosahexaenoic acid with their abundant 
peaks of 1.15% and 0.67% in our results, were earlier reported to act as an anti-
inflammatory agent. Yet both of them were isolated from the plant, not from microalgae 
species 96. On the other hand, docosahexaenoic acid was reported to enhance the 
antioxidant activity97. 
Similar anti-inflammatory and antioxidant effects were found for linolenic acid with an 
abundance of 0.61% obtained from plant98. In addition to that, eicosapentaenoic acid 
(EPA) with an abundance of 0.37% have been shown to have an anti-inflammatory effect 
and antioxidant properties 99-100. The last compound reported to act as both anti-
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inflammatory and powerful antioxidant and a scavenger of hydroxyl radicals was vitamin 
E with a low abundance of 0.33% in our fraction 101. 
However, the rest of the compounds with the low abundances presented int Table 6 have 
not been previously described for their anti-inflammatory effect. 
Since there were a variety of promising compounds with potential anti-inflammatory 
activities obtained from Tetraselmis sp. CTP4 ethanol extract by GC-MS injection, it was 
not an easy task to speculate and point out the compound causing the anti-inflammatory 
effect observed before. But we do acknowledge that the most abundant compounds in the 
fraction (octadecenoic acid, hexadecatetraenoic acid, and octadecadienoic acid) could 
have strongly contributed. This means that the anti-inflammatory effect could be due to 
the most abundant compounds, or due to a combination of all or some fatty acids with 
low abundancy present in this fraction. In addition, most of the fatty acids are considered 
to be novel anti-anti-inflammatory and antioxidant compounds. 
Nonetheless, we believe that a synergic effect of all the compounds in the fractions cannot 
be ignored. For the purpose of inspecting this, more research is required. The fraction of 
hexane must be further fractionated into multiple other sub-fractions in order to reduce 
the number of compounds present in each subfraction and the activity would be increased 
in some of those, as a number of active compounds would be limited in each sub-fraction. 
However, if one compound is responsible and is purified, and re-tested again, giving 
promising results, it could be considered as a new potential anti-inflammatory agent. 
However, because of the lack of the time and the fractions quantity prepared we decided 
not to investigate the antioxidant properties for the fractions obtained Tetraselmis sp. 
CTP4 Also, both dichloromethane and ethyl acetate fractions were not characterized by 
GC/MS in spite of their anti-inflammatory activity. T.chuii extract was not fractionated 
as well. To our knowledge, there are no publications reporting anti-inflammatory nor anti-
oxidant effect for both of hexane fraction and extract of  Tetraselmis sp. CTP4 microalga. 
Furthermore, there are no studies which describe the association between the compounds 
detected in this study and the anti-inflammatory effect of Tetraselmis sp. CTP4 against 
Mac THP-1 cells.  
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Table 6: Chemical composition of the hexane fraction determined by GC-MS. The percentage of each 
compound represents its relative abundance in the whole chromatogram. 
RT Tentatively identified compound % of the total peak 
area 
25.62 Octadecenoic acid 28.71 
22.36 hexadecatrienoic acid 12.63 
25.62 Octadecadienoic acid 6.12 
22.13 trans-octadecadienoic acid 6.12 
24.00 stearidonic acid 4.49 
20.91 Tetrahydropyranyl ether of citronellol 2.96 
31.08 2-Norpinanol, 3,6,6-trimethyl- 2.96 
24.00 Tetrahydrofuran, 2-methyl-5-pentyl- 2.96 
25.91 Heptadecanoic acid 2.79 
26.02 Octadecatrienoic acid 2.79 
24.11 eicosatetraenoic acid 2.01 
22.44 9,12-Hexadecadienoic acid 1.95 
26.31 Hexadecenoic acid 1.61 
26.59 cis-9-hexadecenoic acid 1.61 
20.91 Phytol, acetate 1.52 
20.91 9-Hexadecen-1-ol  1.51 
21.85 9-Eicosyne 1.51 
18.08 eicosenoic acid 1.18 
30.67 10-Undecenoic acid 1.15 
31.08 Valeric acid 1.15 
23.54 Heneicosapentaenoic Acid 0.84 
26.72 Myristoleic acid 0.82 
31.52 Stearic acid 0.68 
31.52 Docosahexaenoic acid 0.67 
22.01 linolenic acid 0.61 
22.24 Hexadecatrienoic acid 0.61 
21.85 Tetrahydropyran 12-tetradecyn-1-ol ether 0.60 
27.01 Lup-20(29)-en-21-ol, 3,28-bis[(tetrahydro) 0.60 
27.40 (1-Methoxy-pentyl)-cyclopropane 0.60 
27.40 7-Heptadecene, 17-chloro- 0.59 
30.53 7-hexadecenic acid 0.59 
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27.77 Cholestan-3-one, 4,4-dimethyl-, cyclic 3 0.48 
30.53 Tetrahydrofuran-2-one, 3-[2-pentenyl]-4-methyl- 0.48 
23.15 Eicosapentaenoic acid 0.37 
18.08 Tetradecanoic acid 0.37 
41.58 Arachidonic acid 0.35 
22.96 Pregna-5,9(11)-dien-20-ol-3-one ethylene 0.34 
22.44 Vitamin E 0.34 
19.69 pentadecanoic acid 0.27 
19.13 cis-10-Heptadecenoic acid 0.26 
28.74 unknown compound  0.74 
 
4. CONCLUSION  
 
Tetraselmis sp. CTP4 was isolated and characterized recently as a robust, euryhaline, 
lipid-rich microalga. This genus belongs to the Chlorophyta, family Chlorodendraceae. 
This species is unicellular flagellate with elliptical or almost spherical, slightly flattened 
cells. 
In addition Tetraselmis sp. CTP4 be used as human food, it can also be used in the 
production of fish feed, biofuels and even to treat sewage102. Microalgae are not yet 
considered as traditional food, and this microalga needs to undergo an EU approval 
process, in order to be actually marketed for human consumption, which still takes some 
time. However, this species is a rich source of lipids since it has been reported recently 
has a high potential for biotechnological applications1 
 Herein, we are presenting for the first time, that Tetraselmis sp. CTP4 ethanol extract has 
a strong anti-inflammatory activity against human macrophages differentiated from 
monocytic leukemia (THP-1) cell line. More specifically, the hexane fraction obtained 
from this extract was found to have a  % of TNF  inhibition higher than dexamethasone, 
frequently used as an anti-inflammatory drug for inflammation treatment. However, the 
antioxidant activity for this extract was not that high. 
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The GC-MS analysis of hexane fraction revealed 12 compounds potentially (according to 
the literature) responsible for the anti-inflammatory activity, and 8 of them might be 
responsible for the antioxidant activity. More studies are needed in order to purify those 
compounds and test each compound separately in order to identify the compound 
responsible for the effect observed. 
 Recommendations for the future work include additional fractionation to obtain more 
potentially active fractions, with a more limited number of compounds, and to perform 
characterization with NMR. Nevertheless, our results suggest that Tetraselmis sp. CTP4 
is a source of promising anti-inflammatory agents. T. chuii ethanol extract should be 
further investigated hence it possesses higher anti-inflammatory effect at the lowest 
concentration. Furthermore, dichloromethane and ethyl acetate fractions from 
Tetraselmis sp. CTP4 Ethanol extract, should be further characterized hence they 
displayed a high TNF-α inhibition (anti-inflammatory effect) results. In addition to the 
identification of compounds from the hexane fraction by GC-MS, those compounds 
should be purified and tested for their anti-inflammatory effect, in order to obtain pure 
drug leads with proved anti-inflammatory effect. Last but not least, HPLC analysis should 
be done in order to detect non-volatile compounds, such as some carotenoids, which 
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